OUTRUN THERAPEUTICS LIMITED

Active United Kingdom

Other human health activities

9 employees website.com
Life sciences and medical technology Other human health activities
O

OUTRUN THERAPEUTICS LIMITED

Other human health activities

Founded 26 Nov 2019 Active United Kingdom 9 employees website.com
Life sciences and medical technology Other human health activities
Accounts Submitted 7 May 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 7 Apr 2026 Next due 26 Mar 2027 11 months remaining
Net assets £-3M £3M 2024 year on year
Total assets £4M £335K 2024 year on year
Total Liabilities £7M £3M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for OUTRUN THERAPEUTICS LIMITED (SC648164), an active life sciences and medical technology company based in United Kingdom. Incorporated 26 Nov 2019. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£2.94M

Decreased by £404.91k (-12%)

Net Assets

-£3.48M

Decreased by £3.40M (-4245%)

Total Liabilities

£7.31M

Increased by £3.07M (+72%)

Turnover

N/A

Employees

9

Increased by 4 (+80%)

Debt Ratio

191%

Increased by 89 (+87%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2024Seed
Investor 2Apr 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 13,122,308 Shares £15.14m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Feb 202610,676,256£9.14m£0.856
27 Feb 20261,868,096£2.00m£1.071
19 Feb 202611,508£11.508£0.001
20 Feb 20241,449£1.449£0.001
22 Feb 2022266,666£2.67m£10

Officers

Officers

2 active 1 resigned
Status
Johnson, Anthony GerardDirectorAmericanUnited States6823 Sept 2022Active
Roberts, Christopher, DrDirectorAmericanUnited States5614 Jul 2021Active

Shareholders

Shareholders (4)

Merck Ventures B.v.
35.4%
Satpal Singh Virdee
23.2%

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Mitsubishi Chemical Holdings Corporation

Japan

Active
Notified 22 Jan 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Merck Kgaa

Germany

Active
Notified 22 Jan 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Satpal Singh Virdee

Ceased 22 Jan 2022

Ceased

University Of Dundee (the)

Ceased 5 Mar 2021

Ceased

Group Structure

Group Structure

OUTRUN THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Apr 2026Confirmation StatementConfirmation statement made on 2026-03-12 with updates
17 Mar 2026CapitalAllotment of shares (GBP 13,122.309) on 2026-02-27
13 Mar 2026CapitalAllotment of shares (GBP 577.957) on 2026-02-19
13 Mar 2026IncorporationMemorandum Articles
13 Mar 2026ResolutionResolutions
7 Apr 2026 Confirmation Statement

Confirmation statement made on 2026-03-12 with updates

17 Mar 2026 Capital

Allotment of shares (GBP 13,122.309) on 2026-02-27

13 Mar 2026 Capital

Allotment of shares (GBP 577.957) on 2026-02-19

13 Mar 2026 Incorporation

Memorandum Articles

13 Mar 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-12 with updates

1 weeks ago on 7 Apr 2026

Allotment of shares (GBP 13,122.309) on 2026-02-27

1 months ago on 17 Mar 2026

Allotment of shares (GBP 577.957) on 2026-02-19

1 months ago on 13 Mar 2026

Memorandum Articles

1 months ago on 13 Mar 2026

Resolutions

1 months ago on 13 Mar 2026